Topics

Is Mea A Controlled Substance Nitrosamine And Precursor Considerations

Industrial monoethanolamine (MEA; CAS 141-43-5) is a primary alkanolamine with a molecular weight of 61.08 g/mol, a normal boiling point of 170.8 °C at 101.3 kPa, and a freezing point of 10.3 °C. A 100 g/L aqueous solution produces a pH above 11.8, consistent with the conjugate-acid pKa of 9.55. Bulk MEA is fully miscible with water and is processed in acid-gas scrubbers, metalworking-fluid pH buffers, detergent amidification, and alkoxylation units. The compound's dual hydroxyl and amine functionality creates two distinct regulatory pressure points: a mistaken assumption that all ethanolamines share controlled-substance schedules, and a separate nitrosamine risk that arises mainly from diethanolamine co-impurity rather than from MEA itself. The regulatory question “Is MEA a controlled substance?” and the associated nitrosamine and precursor considerations are therefore not identical.

Is Monoethanolamine a Controlled Substance Under DEA, EU, and CWC Precursor Lists?

MEA is not listed as a controlled substance in the United States under 21 CFR 1308.11–1308.15, the Drug Enforcement Administration Schedules I–V. It is also absent from the DEA List I and List II chemical inventories in 21 CFR 1310.02. A facility that imports, stores, or processes MEA therefore does not require DEA registration solely because of MEA; however, site-level DEA registration remains necessary if the facility also handles scheduled substances or listed chemicals. The absence of MEA from the list does not exempt the material from general hazardous-material security, occupational exposure, or process safety management duties. In the European Union, MEA is not named in Regulation (EC) No 273/2004 or Council Regulation (EC) No 111/2005, the principal drug-precursor control instruments. Canada does not list ethanolamine in Schedules I–VI of the Controlled Drugs and Substances Act.

The Chemical Weapons Convention supply-chain trigger is frequently confused at import and export screening: ethanolamine is not present in Schedules 1, 2, or 3, while triethanolamine (CAS 102-71-6) is listed in Schedule 3.B as a dual-use precursor. Export-control staff must compare the CAS number on the bill of lading against the actual schedule because a container of triethanolamine cannot be cleared as if it were monoethanolamine. Occupational exposure standards remain applicable: OSHA assigns a permissible exposure limit of 3 ppm as an 8-hour time-weighted average under 29 CFR 1910.1000 Table Z-1, and NIOSH lists a 15-minute short-term exposure limit of 6 ppm. EPCRA Section 313 reporting applies because ethanolamine is a listed toxic chemical under 40 CFR 372.65. GHS classification under EU CLP includes Skin Corr. 1B with H314, Acute Tox. 4 with H302/H312/H332, Eye Dam. 1 with H318, STOT SE 3 with H335, and Aquatic Chronic 3 with H412.

Regulatory frameworkControl statusLegal reference
United States DEANot scheduled; not List I/II21 CFR 1308.11–1308.15; 21 CFR 1310.02
United States OSHAPEL 3 ppm 8-hour TWA29 CFR 1910.1000 Table Z-1
United States NIOSHSTEL 6 ppm 15-minuteNIOSH Pocket Guide
European UnionSkin Corr. 1B; Acute Tox. 4; Eye Dam. 1; STOT SE 3; Aquatic Chronic 3Regulation (EC) No 1272/2008
European Union drug precursorsNot listedRegulation (EC) No 273/2004; Council Regulation (EC) No 111/2005
Chemical Weapons ConventionMEA not listed; triethanolamine listed Schedule 3.BCWC Annex on Chemicals

Nitrosation Kinetics of Primary versus Secondary Alkanolamines at Production-Relevant pH and Temperature

Nitrosamine formation is governed by the availability of the nitrosating agent, usually nitrous anhydride or nitrosonium ion derived from nitrite under acidic conditions. In aqueous solution, nitrite converts to nitrous acid with a pKa of 3.15; the reactive N2O3 concentration rises rapidly as pH falls below 5.0. Secondary amines undergo direct N-nitrosation to stable N-nitrosamines. Tertiary amines can generate nitrosamines through dealkylation under oxidative or acidic conditions. Monoethanolamine is a primary amine; nitrosation produces a primary N-nitrosamine intermediate that is not stable and decomposes through a diazonium species. The result is that pure MEA does not form a persistent N-nitrosamine under ordinary aqueous formulation or gas-treating conditions. The mechanistic distinction is often omitted in generic nitrosamine risk assessments, leading to over-application of secondary-amine limits to a primary alkanolamine.

The industrial risk with MEA is not the primary amine itself but diethanolamine carried as a co-product. Technical-grade MEA commonly contains DEA at 0.1 wt% to 0.3 wt%, depending on the ethylene oxide-to-ammonia molar ratio and the distillation cut points in the refining train. Low-DEA grades can be produced by fractional distillation to a specification of DEA ≤0.1 wt%, but the default grade is not automatically low-DEA. DEA is a secondary amine and reacts with nitrite to form N-nitrosodiethanolamine, classified by IARC as Group 2B and subject to pharmaceutical nitrosamine acceptable-intake limits. The European Medicines Agency has published a substance-specific acceptable intake for NDELA of 26.5 ng/day; FDA's nitrosamine guidance requires that manufacturers of drug products containing amine-functional excipients assess nitrite sources and processing conditions when a secondary amine impurity is present.

The pH and thermal boundaries matter in production environments. In metalworking fluid concentrates and pharmaceutical granulation, nitrosation of DEA is negligible above pH 6.5 but becomes measurable below pH 4.5 if nitrite is available. Drying above 60 °C after acid granulation can concentrate the reactants and accelerate NDELA formation. Nitrite sources include sodium nitrite corrosion inhibitors, recycled process water, and nitrogen oxide absorption into amine solutions. A high-shear wet granulator operating at pH 3.8 to 4.2 with a filler containing sodium nitrite at 250 mg/kg can generate NDELA above the method limit of quantitation when the MEA binder contains DEA above 0.2 wt%; published data for that exact multi-excipient configuration is limited, but the mechanistic prerequisites are well established. Control therefore concentrates on reducing DEA content, eliminating nitrite from the formula, or shifting the process pH out of the nitrosation window.

Nitrosamine risk parameterMEA primary amineDEA secondary amine impurity
Reactive nitrosating speciesN2O3/HNO2 below pH 5.0N2O3/HNO2 below pH 5.0
Stable N-nitrosamine formedNo; primary N-nitrosamine decomposesYes; NDELA
IARC classificationNot assigned for direct MEA nitrosamineGroup 2B for NDELA
Acceptable intake in pharmaceuticalsNot assigned for MEA-derived nitrosamine26.5 ng/day EMA
Typical raw material limitAssay ≥99.0 wt%DEA ≤0.1–0.3 wt%
Process control boundaryNot applicable for stable nitrosaminepH ≥6.5 or nitrite-free

Precursor screening for MEA should be performed at the CAS level rather than by chemical family. Although triethanolamine is a Chemical Weapons Convention Schedule 3.B precursor and is often grouped with MEA in ethylene oxide/ammonia production trains, MEA is not subject to the same CWC declaration or end-use documentation requirements. Bulk MEA shipments do not require Schedule 3 annual declarations; however, sites that co-produce or co-ship triethanolamine must maintain separate inventory records because a Schedule 3 chemical cannot be reported under the MEA CAS number. Under EU drug precursor control, MEA does not trigger the licensing and customer-declaration duties imposed on listed substances. Import control staff should still verify that the HS code and CAS number on the safety data sheet match 141-43-5, because misdeclared triethanolamine has been a recurring traceability problem at upstream distribution terminals.

MEA is a synthetic precursor to aziridine through vapor-phase dehydration over a solid acid catalyst at elevated temperature. Aziridine is not a controlled substance under DEA schedules, but it is a highly reactive and toxicologically potent intermediate with its own exposure limits. A reactor that converts MEA to aziridine typically operates above 300 °C; the unit should be equipped with continuous headspace scrubbing and rapid quench because residual aziridine is volatile and can polymerize exothermically in storage. This precursor route does not confer controlled-substance status on MEA, but it does create a process-safety and occupational-exposure boundary that must be separated from the nitrosamine question.

The second precursor consideration is environmental: MEA can react with nitrogen oxides in flue gas or with nitrite-containing wastewater to form transient nitroso or diazo intermediates. Discharge permit limits for MEA are typically based on chemical oxygen demand and ammonia, not controlled-substance reporting. In a production-scale acid-gas absorber using 30 wt% aqueous MEA, the reboiler is maintained at 121–124 °C with lean loading near 0.25 mol CO2/mol MEA; nitrosamine formation in the absorber circuit is not observed unless the circulating amine is contaminated with secondary amines and nitrite. Published industrial data for nitrosamine accumulation in gas-treating systems is limited, and ongoing monitoring is recommended where the flue gas contains NOx above 50 ppmv.

When Secondary Amine Contaminants and Nitrite Sources Override the Primary Amine Advantage

In formulated products, MEA cannot be treated as a binary pure substance. The nitrosamine risk assessment must include the full formulation because MEA is often combined with nitrite-based corrosion inhibitors in metalworking fluids or with nitrite-containing excipients in pharmaceuticals. A secondary amine can also be introduced by another raw material, such as diethanolamine, morpholine, or dimethylamine, even if the MEA itself meets a low-DEA specification. Under those conditions, the primary-amine advantage of MEA becomes irrelevant: the secondary amine controls nitrosamine potential.

For liquid systems, the analytical workflow should include LC-MS/MS with isotope-labeled internal standards and a limit of quantitation not higher than 10 ng/g for each identified N-nitrosamine. The FDA guidance for nitrosamine impurities recommends confirmatory methods when a detected peak exceeds the limit of quantitation, and a control strategy that documents nitrite levels in each lot of critical excipients. Nitrite in excipients can be quantified by ion chromatography with a method quantitation limit of 1 mg/kg or lower. Where nitrite is unavoidable, the process should maintain pH above 6.5, reduce residence time, or substitute a non-nitrite corrosion inhibitor. In metalworking fluid concentrates, the combination of MEA, secondary amine impurities, and sodium nitrite creates a pH-dependent NDELA formation risk; concentrates should be tested after storage for 30 days at 40 °C because NDELA can form during warehouse aging, not only during active mixing.

The operational incompatibility is direct: do not combine MEA with sodium nitrite or nitrous acid in acidic storage or process lines. A bulk storage tank that previously held a nitrite-containing corrosion inhibitor must be rinsed before MEA service if residual acid is present; closed-loop cleaning with 1–2 wt% citric acid followed by passivation is used in stainless steel systems, but the acid rinse must be drained and the vessel dried before MEA loading to avoid low-pH zones that promote nitrosation of any DEA present. MEA is also incompatible with copper, zinc, and aluminum; storage tanks and distribution piping are typically 304/316 stainless steel or lined carbon steel. Above 40 °C in carbon steel, MEA-water circuits can exhibit amine stress-corrosion cracking, particularly in gas-treating reboilers with high residual tensile stress. The pH of MEA solutions and the corrosion inhibitor package must be managed as a single system; changing from a nitrite inhibitor to a phosphate or carboxylate inhibitor removes the nitrosating source but requires revalidation of corrosion protection under the applicable original equipment manufacturer test protocol.

Top